Literature DB >> 14519480

Arginine flux and nitric oxide production during human pregnancy and postpartum.

Linda A Goodrum1, George R Saade, Michael A Belfort, Kenneth J Moise, Farook Jahoor.   

Abstract

OBJECTIVE: To compare second-trimester, third-trimester, and postpartum arginine flux and nitric oxide production using infusions of the stable isotope L-[(15)N(2)]-arginine in normal human gestation.
METHODS: Kinetic measurements were made in pregnant volunteers with uncomplicated singleton gestations in mid gestation, late gestation, and more than 8 weeks postpartum. A bolus of 4.95 micromol/kg of labeled arginine was administered, followed by an infusion at 4.95 micromol/kg per hour for 6 hours. The isotopic enrichment of plasma arginine and nitrite or nitrate (NO(x)) was determined by gas chromatography, mass spectrometry, or both. We used the Kolmogorov-Smirnov test for normality, repeated-measures analysis of variance, and Newman-Keuls test. P <.05 denoted statistical significance.
RESULTS: The rate of turnover of the intravascular NO(x) pool was significantly higher in mid gestation compared with late gestation and almost reached statistical significance when compared with postpartum values (6.2 +/- 0.9 versus 4.3 +/- 0.8 [P <.02] versus 3.7 +/- 2.1% pool/hour; P =.08). Arginine flux was significantly higher in early compared with late gestation and postpartum (107.8 +/- 13.9 versus 72.5 +/- 16.1 versus 82 +/- 8.8 micromol/kg per hour, respectively; P <.01).
CONCLUSION: Arginine and nitric oxide production is higher in mid gestation. This suggests a role for nitric oxide in early cardiovascular adaptation in human gestations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14519480     DOI: 10.1016/s1071-5576(03)00137-0

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  4 in total

Review 1.  Perspective: L-arginine and L-citrulline Supplementation in Pregnancy: A Potential Strategy to Improve Birth Outcomes in Low-Resource Settings.

Authors:  Andrea M Weckman; Chloe R McDonald; Jo-Anna B Baxter; Wafaie W Fawzi; Andrea L Conroy; Kevin C Kain
Journal:  Adv Nutr       Date:  2019-09-01       Impact factor: 8.701

2.  Malaria in pregnancy alters l-arginine bioavailability and placental vascular development.

Authors:  Chloe R McDonald; Lindsay S Cahill; Joel L Gamble; Robyn Elphinstone; Lisa M Gazdzinski; Kathleen J Y Zhong; Adrienne C Philson; Mwayiwawo Madanitsa; Linda Kalilani-Phiri; Victor Mwapasa; Feiko O Ter Kuile; John G Sled; Andrea L Conroy; Kevin C Kain
Journal:  Sci Transl Med       Date:  2018-03-07       Impact factor: 17.956

3.  In vivo arginine production and nitric oxide synthesis in pregnant Indian women with normal and low body mass indices.

Authors:  A V Kurpad; C Kao; P Dwarkanath; S Muthayya; A Mhaskar; A Thomas; M Vaz; F Jahoor
Journal:  Eur J Clin Nutr       Date:  2009-05-13       Impact factor: 4.016

4.  Complement Activation in Placental Malaria.

Authors:  Chloe R McDonald; Vanessa Tran; Kevin C Kain
Journal:  Front Microbiol       Date:  2015-12-21       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.